methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-enoate

Catalog No. :
ACPODO168
CAS No. :
2257430-02-5
Molecular Formula :
C12H21BO4
Molecular Weight :
240.11

IUPAC Name:methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-enoate

methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-enoate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$258.00Login to see priceIn stockInquiry
100mg95%$381.00Login to see priceIn stockInquiry
250mg95%$542.00Login to see priceIn stockInquiry
1g95%$1512.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Namemethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-enoate
IUPAC Namemethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-enoate
Molecular FormulaC12H21BO4
Molecular Weight240.11
SMILESO=C(CCC(B1OC(C)(C(C)(C)O1)C)=C)OC
InChI KeyDPDGPZXWILXBHF-UHFFFAOYSA-N
SynonymMethyl 4,4,5,5-tetramethyl-γ-methylene-1,3,2-dioxaborolane-2-butanoate
CAS No.2257430-02-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P363-P501

Synthetic Route by SureRoute

1. ACPODO168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQAPN437 route compound structure diagram
    ACQAPN43721565-82-2 In Stock
  2. Plus
  3. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  4. Then
  5. ACPODO168 route product structure diagram
    ACPODO1682257430-02-5 In Stock
Inquiry

2. ACPODO168 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPODO168 route product structure diagram
    ACPODO1682257430-02-5 In Stock
Inquiry

Comments (0)